GenEp
Charlottesville, VA
GenEp, Inc. is a pre-clinical stage biotechnology company based on intellectual property assets. GenEp creates therapies targeting mutations of sodium and other ion channels that cause rare genetic epilepsies and other treatment-resistant epilepsies.
genepbio.comCompany Details
Founded
- 2021
Employees
- Between 5 - 10 employees
Raised
- $10,404,992
Headquarters Location
- Charlottesville, VA
Public
- No
Acquired
- No
CEO
Andrew Krouse
Company Collections
These are collections GenEp is a part of. Click on the collection name to view similar companies.